Drug intelligence / Profile preview

AlphaBRAIN

Development stage
Unknown
Lead developer
Onnit
Administration
Oral
01

Overview

**AlphaBRAIN** is a dietary supplement marketed as a nootropic for supporting cognitive functions such as memory, focus, and mental processing speed[1][4][5]. Developed and manufactured by Onnit, AlphaBRAIN consists of a blend of vitamins, herbs, and amino acids, divided into proprietary blends targeting different putative mechanisms: enhancement of *acetylcholine* levels, promotion of *alpha brain wave* production, and support for nervous system communication[1][2][4]. Notably, it contains no caffeine. Key ingredients include Vitamin B6, alpha-GPC, Bacopa monnieri, Huperzia serrata (source of huperzine A, an acetylcholinesterase inhibitor), oat straw extract, L-tyrosine, L-theanine, phosphatidylserine, cat’s claw extract, L-leucine, vinpocetine, and pterostilbene. AlphaBRAIN is not approved as a pharmaceutical and is sold as a dietary supplement. The exact efficacy and safety profile remains uncertain due to underdisclosed dosages and limited independent research[1][2][4].

Brand names
AlphaBRAIN
Other names
AlphaBRAIN
02

Targets

Acetylcholinesterase

Beyond the preview

Go deeper on AlphaBRAIN.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AlphaBRAIN.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call